|
1
|
Ullah MF: Breast cancer: Current
perspectives on the disease status. Adv Exp Med Biol. 1152:51–64.
2019. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
D'Alterio C, Scala S, Sozzi G, Roz L and
Bertolini G: Paradoxical effects of chemotherapy on tumor relapse
and metastasis promotion. Semin Cancer Biol. 60:351–361. 2020.
View Article : Google Scholar
|
|
5
|
Keklikoglou I, Cianciaruso C, Güç E,
Squadrito ML, Spring LM, Tazzyman S, Lambein L, Poissonnier A,
Ferraro GB, Baer C, et al: Chemotherapy elicits pro-metastatic
extracellular vesicles in breast cancer models. Nat Cell Biol.
21:190–202. 2019. View Article : Google Scholar
|
|
6
|
Han J, Bai Y, Wang J, Xie XL, Li AD, Ding
Q, Cui ZJ, Yin J, Jiang XY and Jiang HQ: REC8 promotes tumor
migration, invasion and angiogenesis by targeting the PKA pathway
in hepatocellular carcinoma. Clin Exp Med. 21:479–492. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Sohaily S, Biankin A, Leong R, Corish
MK and Warusavitarne J: Molecular pathways in colorectal cancer. J
Gastroenterol Hepatol. 27:1423–1431. 2012. View Article : Google Scholar
|
|
8
|
Ly P, Brunner SF, Shoshani O, Kim DH, Lan
W, Pyntikova T, Flanagan AM, Behjati S, Page DC, Campbell PJ and
Cleveland DW: Chromosome segregation errors generate a diverse
spectrum of simple and complex genomic rearrangements. Nat Genet.
51:705–715. 2019. View Article : Google Scholar
|
|
9
|
Liu D, Shen X, Zhu G and Xing M: REC8 is a
novel tumor suppressor gene epigenetically robustly targeted by the
PI3K pathway in thyroid cancer. Oncotarget. 6:39211–39224. 2015.
View Article : Google Scholar
|
|
10
|
Zhao J, Geng L, Duan G, Xu W, Cheng Y,
Huang Z, Zhou Z and Gong S: REC8 inhibits EMT by downregulating
EGR1 in gastric cancer cells. Oncol Rep. 39:1583–1590.
2018.PubMed/NCBI
|
|
11
|
Gu Q, Li F, Ge S, Zhang F, Jia R and Fan
X: CDC20 Knockdown and acidic microenvironment collaboratively
promote tumorigenesis through inhibiting autophagy and apoptosis.
Mol Ther Oncolytics. 30:94–106. 2020. View Article : Google Scholar
|
|
12
|
Guo C, Kong F, Lv Y, Gao N, Xiu X and Sun
X: CDC20 inhibitor apcin inhibits embryo implantation in vivo and
in vitro. Cell Biochem Funct. 6:810–816. 2020. View Article : Google Scholar
|
|
13
|
Zhang Q, Huang H, Liu A, Li J, Liu C, Sun
B, Chen L, Gao L, Xu D and Su C: Cell division cycle 20 (CDC20)
drives prostate cancer progression via stabilization of β-catenin
in cancer stem-like cells. EBioMedicine. 42:397–407. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karra H, Repo H, Ahonen I, Löyttyniemi E,
Pitkänen R, Lintunen M, Kuopio T, Söderström M and Kronqvist P:
Cdc20 and securin overexpression predict short-term breast cancer
survival. Br J Cancer. 12:2905–2913. 2014. View Article : Google Scholar
|
|
15
|
Alfarsi LH, Ansari RE, Craze ML, Toss MS,
Masisi B, Ellis LO, Rakha EA and Green AR: CDC20 expression in
oestrogen receptor positive breast cancer predicts poor prognosis
and lack of response to endocrine therapy. Breast Cancer Res Treat.
178:535–544. 2019. View Article : Google Scholar
|
|
16
|
Cheng L, Huang YZ, Chen WX, Shi L, Li Z,
Zhang X, Dai XY, Wei JF and Ding Q: Cell division cycle
proteinising prognostic biomarker of breast cancer. Biosci Rep.
40:BSR201912272020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guerrero-Preston R, Hadar T, Ostrow KL,
Soudry E, Echenique M, Ili-Gangas CL, Pérez G, Perez J, Mieville
PB, Deschamps .et al: Differential promoter methylation of kinesin
family member 1a in plasma is associated with breast cancer and DNA
repair capacity. Oncol Rep. 32:505–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu J, Liang Q, Wang J, Gao J, Zhang J,
Zeng Y, Chiu PWY, Ng EKW and Sung JJY: REC8 functions as a tumor
suppressor and is epigenetically downregulated in gastric cancer,
especially in EBV-positive subtype. Oncogene. 36:182–193. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu M, Xu W, Su M and Fan P: REC8
suppresses tumor angiogenesis by inhibition of NF-κB-mediated
vascular endothelial growth factor expression in gastric cancer
cells. Biol Res. 53:412020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kapanidou M, Curtis NL and Bolanos-Garcia
VM: Cdc20: At the crossroads between chromosome segregation and
mitotic exit. Trends Biochem Sci. 42:193–205. 2017. View Article : Google Scholar
|
|
23
|
Li D, Zhu J, Firozi PF, Abbruzzese JL,
Evans DB, Cleary K, Friess H and Sen S: Overexpression of oncogenic
STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer
Res. 9:991–997. 2003.PubMed/NCBI
|
|
24
|
Zhang W, Gong W, Ai H, Tang J and Shen C:
Gene expression analysis of lung adenocarcinoma and matched
adjacent non-tumor lung tissue. Tumori. 100:338–345. 2014.
|
|
25
|
Li J, Gao JZ, Du JL, Huang ZX and Wei LX:
Increased CDC20 expression is associated with development and
progression of hepatocellular carcinoma. Int J Oncol. 45:1547–1555.
2014. View Article : Google Scholar
|
